Clinical trial

Renal Transplantation and Raltegravir in HIV-Infected Patients

NCT01453192

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Raltegravir Normalized identity: raltegravirView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Renal Transplantation and Raltegravir in HIV-Infected Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-12-01

PhasePHASE3

Conditions

HIV-1 Infectionunresolved

Chronic Renal Insufficiencyunresolved

Interventions

RaltegravirDRUG · verified · RxNorm: raltegravir

Sponsors & collaborators

ANRS, Emerging Infectious Diseaseslead sponsor

Merck Sharp & Dohme LLCcollaborator

Mapped research locations

ParisFrance3 ToulouseFrance1 StrasbourgFrance1 LilleFrance1 BordeauxFrance1 NantesFrance1 NiceFrance1 CaenFrance1 CréteilFrance1 ToursFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01453192 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.